C
Charalampos Loutradis
Researcher at Aristotle University of Thessaloniki
Publications - 91
Citations - 1209
Charalampos Loutradis is an academic researcher from Aristotle University of Thessaloniki. The author has contributed to research in topics: Ambulatory blood pressure & Kidney disease. The author has an hindex of 15, co-authored 81 publications receiving 651 citations. Previous affiliations of Charalampos Loutradis include University Hospitals Birmingham NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients
Pantelis Sarafidis,Charalampos Loutradis,Antonios Karpetas,Georgios Tzanis,Alexia Piperidou,Georgios Koutroumpas,Vasilios Raptis,Christos Syrgkanis,Vasilios Liakopoulos,Georgios Efstratiadis,G. London,Carmine Zoccali +11 more
TL;DR: It is found that arterial stiffness is the prominent cardiovascular risk factor in hemodialysis and Ambulatory PWV, AIx(75), and central pulse pressure are associated with increased risk of cardiovascular events and mortality, whereas office and ambulatory SBP are not.
Journal ArticleDOI
The effect of dry-weight reduction guided by lung ultrasound on ambulatory blood pressure in hemodialysis patients: a randomized controlled trial
Charalampos Loutradis,Pantelis Sarafidis,Robert Ekart,Christodoulos Papadopoulos,Vasileios Sachpekidis,Maria Eleni Alexandrou,Dorothea Papadopoulou,Giorgos Efstratiadis,Aikaterini Papagianni,Gérard M. London,Carmine Zoccali +10 more
TL;DR: A lung-ultrasound-guided strategy for dry-weight reduction can effectively and safely reduce ambulatory BP levels in hemodialysis patients and clinical implementation of this simple technique can help increase BP control in this population of patients with hypertension.
Journal ArticleDOI
Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.
Pantelis Sarafidis,Luis M. Ruilope,Luis M. Ruilope,Charalampos Loutradis,Manuel Gorostidi,Alejandro de la Sierra,Juan J. de la Cruz,Ernest Vinyoles,J A Divisón-Garrote,Julian Segura,José R. Banegas +10 more
TL;DR: An increase in short-term SBP-variability was present with advancing CKD stages in a large cohort and may be involved in the sharp elevation of cardiovascular risk with worsening renal function.
Journal ArticleDOI
Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study
Charalampos Loutradis,Alexandra Skodra,Panagiotis I. Georgianos,Panagiota Tolika,Dimitris Alexandrou,Afroditi Avdelidou,Pantelis Sarafidis +6 more
TL;DR: Prevalence of anemia progressively increases with advancing stages of CKD and is higher in diabetic than matched non-diabetic CKD patients and diabetes is independently associated with anemia occurrence.
Journal ArticleDOI
Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.
Maria-Eleni Alexandrou,Aikaterini Papagianni,Apostolos Tsapas,Charalampos Loutradis,Afroditi K. Boutou,Alexia Piperidou,Dorothea Papadopoulou,Luis M. Ruilope,George L. Bakris,Pantelis Sarafidis +9 more
TL;DR: Use of MRAs alone or on top of RAS blockade confers important antiproteinuric effects in patients with CKD, with a slight increase in mean potassium levels.